Output Explorer

Every prompt in the paper, and what each model wrote back.

Return exactly ten single-sentence facts as JSON. Quality was judged pairwise; here you see the raw outputs and whether the JSON parsed.

13 of 1,000 prompts

TEX · Q3 20252025-10-30 ACA · Q3 20252025-10-31 CSV · Q4 20252026-02-26 MDBH · Q3 20252025-11-20 HSTM · Q2 20252025-08-05 NVDA · Q4 20262026-02-25 TCMD · Q1 20262026-05-04 SMRT · Q2 20252025-08-06 LC · Q3 20252025-10-22 STEP · Q2 20262025-11-06 TSCO · Q4 20252026-01-29 AXGN · Q1 20262026-04-28 CXM · Q2 20262025-09-03

Nearby prompts. All 1,000 Earnings calls prompts

PromptTCMD· Q1 2026 · call on2026-05-04· transcript 46,013 characters

Analyze the following earnings call transcript and extract the 10 most investor-relevant facts.

Each fact must:
- Be drawn only from the transcript (do not use any outside information).
- Be a single sentence capturing a specific, quantified insight relevant to investors.
- Avoid regurgitating the transcript verbatim; instead, synthesize and distill the information into investor-relevant facts.

Return only a JSON object with this exact structure (no markdown fences, no commentary):
{"facts": ["<fact 1>", "<fact 2>", ..., "<fact 10>"]}

The list must contain exactly 10 facts.

Transcript:
<transcript>
transcript redacted — the source calls are not publicly licensed
</transcript>

System prompt · identical for every setup

You are a financial analyst. You extract the most investor-relevant facts from earnings call transcripts to help investors anticipate the stock's reaction to the call.

Reference

No reference summary is published. Quality was judged pairwise by a separate model and is reported in aggregate on the main page.

Ours

10 facts · valid JSON

Tactile Medical reported Q1 2026 total revenue of $75.3 million, representing a 23% year-over-year increase driven by growth in both business lines.
Lymphedmia division revenue grew 23% to $62.2 million, while airway clearance revenue increased 22% to $13 million on a year-over-year basis.
The company achieved a gross margin of 76.5% in Q1 2026, reflecting a 250 basis point expansion from the prior year due to lower manufacturing costs and favorable product mix.
Adjusted EBITDA turned positive to $3.7 million with a margin of 4.9%, reversing the $0.3 million loss and negative 0.4% margin recorded in Q1 2025.
Tactile raised its full-year 2026 revenue guidance to a range of $360 million to $368 million, representing approximately 9% to 12% year-over-year growth inclusive of the LymphaTech acquisition.
The Medicare channel for lymphedmia products grew 40% year-over-year in Q1, benefiting from the alignment of documentation criteria with the new National Coverage Determination (NCD) and recent order acceleration ahead of new prior authorization rules.
The company received FDA 510(k) clearance for its next-generation AffloVest, which features reduced weight and digital connectivity, with commercial launch targeted for the 2026-2027 winter season.
Following the February acquisition of LymphaTech, the company secured a federal GUIDE research grant of which it is one of seven recipients to develop bioimpedance feedback garments.
GAAP operating expenses increased 19% to $59.1 million in Q1, yet the net loss narrowed 41% to $1.2 million or $0.08 per diluted share due to margin expansion and operating leverage improvements.
The company ended Q1 2026 with $75 million in cash and no outstanding borrowings, utilizing capital discipline while annualizing growth investments and absorbing acquisition-related integration costs.

Aux 2015

Invalid JSONshown as written

Based on the transcript, here are the 10 most investor-relevant facts extracted from the Tactile Systems Technology, Inc. earnings call:

Lymphedema revenue grew 23% year-over-year – The company reported strong growth in its lymphedema business, driven by its Flexitouch and Nimbl products.
Airway clearance revenue increased 22% year-over-year – The company's airway clearance product, AffloVest, showed strong growth, driven by its adoption among respiratory specialists.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.
Lymphedema revenue grew 23% year-over-year – The company's go-to-market investments and market share gains are driving growth in its flagship product, Flexitouch.

These facts are drawn directly from the transcript and are quantified insights relevant to investors.

PiT-FT 2015

Invalid JSONshown as written

Transcript of the first quarter 2026 earnings call for Tactile Systems

<transcript> # Transcript of the second quarter 2026 earnings call for Tactile Medical <transcript> # Transcript of the third quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fourth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fifth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the sixth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the seventh quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the eighth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the ninth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the tenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the eleventh quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twelfth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the thirteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fourteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fifteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the sixteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the seventeenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the eighteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the nineteenth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twentieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-first quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-second quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-third quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-fourth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-fifth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-seventh quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-eighth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the twenty-ninth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the thirtieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fortieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026 earnings call for Tactile Systems <transcript> # Transcript of the fiftieth quarter 2026

ChronoGPT 2015

Invalid JSONshown as written


### Final Answer: